Zitiert in 2+ Publikationen.
Der Maus Monoklonal anti-LBP Antikörper (Klon biG33) (ABIN343173) detektiert spezifisch LBP in ELISA.
Dieser Antikörper reagiert spezifisch mit Proben aus Maus.
ELISA ,LBP inhibition studies, Western Blot. inhibits binding of LPS to membrane bound CD14, (Inhibits LPS-binding (0.5 ug/ml) to CD14+CHO cells (2 x 106/ml) up to 1:1000, total inhibition 1:5 Binding titre at mouse LBP- ELISA: 1:50.000 Cross reacting with rat LBP
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Reconstitute with bidistilled water
Konzentration
1 mg/mL
Buffer
PBS, pH 7.17
Konservierungsmittel
Without preservative
Lagerung
-20 °C,-80 °C
Dziarski, Tapping, Tobias: "Binding of bacterial peptidoglycan to CD14." in: The Journal of biological chemistry, Vol. 273, Issue 15, pp. 8680-90, (1998) (PubMed).
Weidemann, Schletter, Dziarski, Kusumoto, Stelter, Rietschel, Flad, Ulmer: "Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes." in: Infection and immunity, Vol. 65, Issue 3, pp. 858-64, (1997) (PubMed).
Target
LBP
(Lipopolysaccharide Binding Protein (LBP))
Andere Bezeichnung
Lipopolysaccharide (LPS)-Binding Protein (LBP)
Hintergrund
Background: Natural LBP is a 58KD glycoprotein produced in liver. It binds at lipid A of LPS with high affinity (10-9M) and reduced the cellular LPS effects at CD14+ cells (IL1ß, IL6, TNFα). It acts as opsonin for GRAM negative cells, LPS, neutrophiles and granulocytes.